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ABSTRACT We have performed molecular dynamics simulations of the interactions of the peptide SP-B1–25, which is
a truncated version of the full pulmonary surfactant protein SP-B, with dipalmitoylphosphatidylcholine monolayers, which are the
major lipid components of lung surfactant. Simulations of durations of 10–20 ns show that persistent hydrogen bonds form
between the donor atoms of the protein and the acceptors of the lipid headgroup and that these bonds determine the position,
orientation, and secondary structure of the peptide in the membrane environment. From an ensemble of initial conditions, the
most probable equilibrium orientation of the a-helix of the peptide is predicted to be parallel to the interface, matching recent
experimental results on model lipid mixtures. Simulations of a few mutated analogs of SP-B1–25 also suggest that the charged
amino acids are important in determining the position of the peptide in the interface. The ﬁrst eight amino acids of the peptide,
also known as the insertion sequence, are found to be essential in reducing the ﬂuctuations and anchoring the peptide in the
lipid/water interface.
INTRODUCTION
Peptide-lipid interactions play a vital role in various bi-
ological processes such as signal transduction, cell fusion, and
protein trafﬁcking. Small membrane peptides are of funda-
mental interest both because of their biological activity and
because they act as models for larger membrane proteins such
as ion channels. Understanding small peptide-lipid interac-
tions is a requisite ﬁrst step toward the understanding of more
complex phenomena seen in larger membrane proteins such
as protein insertion into the membrane, folding in the
membrane, protein-protein association, pore formation, and
signal transduction. Recent experimental and computational
advances have enabled detailed studies of the dynamics and
energetics of interactions between small peptides and lipids
(Simon and McIntosh, 2002). Experimental techniques such
as solid-state NMR, neutron scattering, and x-ray scattering
provide vital information about the ensemble-averaged
peptide-lipid interactions. On the other hand, molecular
dynamics simulations can provide insight about these in-
teractions at a length scale that is still not realizable through
most experiments. However, currently atomistic simulations
are limited by high computational costs, small system sizes,
and, most of all, the short timescale ( nanoseconds) that can be
studied. Nevertheless, simulations, when complemented by
experiments, can give a clearer picture of the systems of
interest than can experiments alone.
Lung surfactant (LS) is a mixture of lipids and proteins
that lines the alveolar epithelial cells of mammalian lungs.
The main biophysical function of LS is to reduce the surface
tension at the air/water interface in the lungs. Dysfunction or
absence of LS leads to respiratory distress syndrome (RDS)
in both neonates and adults. A typical treatment for RDS
involves the use of animal surfactants as a replacement for
human lung surfactant. However, animal sources carry the
danger of viral infection or negative immunological re-
sponse. Thus the production of a synthetic lung surfactant
remains an important research goal and to facilitate this, the
exact nature of the interactions of the various components of
the LS needs to be fully understood.
LS is a mixture of various lipids (saturated, unsaturated,
charged, and neutral), proteins (hydrophilic and hydropho-
bic), fatty acids, and cholesterol. The relative proportions of
these various components vary from species to species.
Dipalmitoylphosphatidylcholine (DPPC), a disaturated zwit-
terionic phospholipid, is the main tensoactive (surface-
tension-reducing) component of LS, constituting ;40–50%
of it by mass. During the compression of the lung, DPPC
packs tightly as a monolayer and enables near-zero surface
tension of the lining of the lung. However, DPPC alone
cannot respread rapidly during the expansion stage and
hence surfactant therapies based on DPPC alone are bound to
fail (Chu et al., 1967). Unsaturated and charged lipids such
as palmitoyloleoylphosphatidylcholine, dipalmitoylphos-
phatidylglycerol (DPPG), and palmitoyloleoylphosphatidyl-
glycerol (POPG) provide the necessary ﬂuidity to obtain
surfactant respreading during the expansion cycle. Nonethe-
less, mixtures of unsaturated lipids and DPPC inadequately
mimic the properties of LS. Numerous in vitro and in vivo
experiments have shown that surfactant protein B (SP-B) and
surfactant protein C greatly enhance the surface properties of
lipid monolayers (Oosterlaken-Dijksterhuis et al., 1991; Hall
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et al., 1992; Yu and Possmayer, 1990, 1992). In particular,
SP-B has been found to be critically important for the proper
respiratory function in vivo (Pryhuber, 1998; Nogee et al.,
1993). LS reconstituted with synthetic phospholipids and
SP-B alone appear to yield full biophysical functioning in
preterm infant rhesus monkeys (Revak et al., 1991, 1996).
The singularly important role of SP-B in facilitating
respiratory function was also shown by genetic knockout
experiments in which mice exhibit RDS when SP-B
production is blocked (Clark et al., 1995). The protein SP-
B is relatively short, containing only 78 amino acid residues.
An even shorter version of the protein, the N-terminal, 25-
amino acid, a-helical peptide SP-B1–25 produces much the
same effect as the whole protein (Bruni et al., 1998). Thus,
a mixture of DPPC, anionic lipids, and SP-B1–25 is an ex-
cellent model for the mammalian lung surfactant.
The sequence of SP-B1–25 in humans is FPIPL PYCWL
CRALI KRIQA MIPKG, with most residues being highly
conserved in other species. The ﬁrst eight residues are highly
hydrophobic and are hypothesized to form an insertion
sequence. This part of the protein is relatively inﬂexible due
to the presence of three alternating proline residues. Residues
9–22 form an amphipathic a-helix, and the last three residues
form a coil motif. A ribbon diagram of SP-B1–25 depicting
the cationic, anionic, and hydrophobic regions is shown in
Fig. 1. Experiments in vitro using model surfactants have
shown that during a compression cycle mimicking that of
breathing, the monolayers get enriched in DPPC through the
squeezing out of non-DPPC lipids and proteins (Yu and
Possmayer, 1992; Taneva and Keough, 1994a,b; Pastrana-
Rios et al., 1994; Kruger et al., 1999), resulting in near-zero
surface tension. The squeezed-out material is stored in
a multilamellar phase directly beneath the monolayer, ready
to be respread into the monolayer during the expansion cycle
of the alveoli (Schurch et al., 1995, 1998). There is
signiﬁcant evidence that SP-B plays a vital role in retaining
the squeezed out lipids near the interface (Nag et al., 1999;
Creuwels et al., 1996). However, recent studies indicate that
ﬂuidity might be a relatively minor determinant of
adsorption and that solid ﬁlms, which resist collapse, can
form by kinetic processes unrelated to equilibrium phase
behavior (Piknova et al., 2002). Thus, the postulated role of
SP-B is still inconclusive. Nevertheless, it is clear that SP-B
interacts differently with DPPC than with other lipids and
this difference is partially responsible for the proper
functioning of the lung. Since DPPC is a zwitterionic lipid,
this suggests possible similarities between lung-surfactant
SP-B peptide and antimicrobial peptides, since the latter
selectively target bacterial membranes, which are inherently
more anionic than eukaryotic membranes. This difference in
lipid composition leads to the disruption of the bacterial
membrane and eventually leads to cell death, although not
affecting the host eukaryote.
Earlier, 2-ns long simulations (Kaznessis et al., 2002)
showed that SP-B1–25 interacts more strongly with DPPG
lipid monolayers than with DPPC monolayers. Their work
also showed that the interactions between the headgroup
regions of the DPPG lipids and the cationic amino acids of
the peptide were particularly strong. This study also revealed
that in DPPG monolayers, the peptide tended to tilt upwards,
inserting its hydrophobic groups into the lipid tail region and
its helical amphipathic region into the lipid headgroup
region, whereas in DPPC monolayers, the peptide was
parallel to the interface, mostly in the water subphase.
However, there is experimental evidence to the contrary,
suggesting a shallow proﬁle for the peptide at the interface
(Wang et al., 2003; Dieudonne et al., 2001; Gordon et al.,
1996 ; Cruz et al., 1998; Lee et al., 2000). Recent ex-
periments by Wang et al. (2003) suggest that in model
LS mixtures, which contain both DPPC and other lipid
components, the peptide adopts a conformation that is
parallel to the interface with the insertion region interacting
with the interface, the cationic amino acids interacting with
the water subphase, and the hydrophobic amino acids of the
helix region interacting with the lipid tail region. Thus, there
is still confusion about the preferred conformation of the SP-
B1–25 peptide in various lipid environments. To elucidate
further the nature of the interactions between SP-B1–25 and
the lipid components, in this report, we study the truncated
lung surfactant protein SP-B1–25 and its mutants, with DPPC
lipid monolayers using molecular dynamics simulations with
FIGURE 1 Snapshot of the lipid/water/peptide monolayer used in the
simulations. The lipids are represented as bonds. Water is shown by blue
dots and the restraining layer of water (the wall) is shown as black spheres.
The peptide is represented as a ribbon. In the ribbon, blue regions represent
anionic amino acids, green regions represent cationic amino acids, and white
regions represent hydrophobic domains. This system consists of 64 DPPC
molecules,;6500 water molecules, and one peptide. The system is periodic
in all three directions. The image was created using visual molecular
dynamics (Humphrey et al., 1996).
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focus on the speciﬁc interactions between the lipid interfacial
region and the polar amino acids of the peptide.
METHODS
We have performed a series of simulations of a monolayer containing 64
DPPC molecules, at a density of 62.5 A˚2/lipid, a peptide, and ;6500 water
molecules. The different stages of the simulations and the conditions
imposed during each stage are provided in Table 1, and the peptides, starting
conditions, and run times are given in Table 2. All the simulations were
performed using the GROMACS simulation package (Berendsen et al.,
1995; Lindahl et al., 2001). The modiﬁed GROMOS united-atom parameter
set was used after downloading from http://moose.bio.ucalgary.ca/down-
load.html, ﬁle: lipid.itp. The peptide structure and coordinates were
downloaded from the Protein Data Bank (code, 1DFW). This peptide was
then used as a template to obtain the mutated peptides MUT1–MUT5. The
software Swiss Protein Data Bank viewer (http://us.expasy.org/spdbv/) was
used to perform the mutations.
Monolayer conﬁguration and equilibration
The system consisted of 64 DPPC lipids in a monolayer leaﬂet,;6500 water
molecules, one peptide, and an appropriate number of counterions to
maintain electroneutrality of the system. (see Fig. 1). The initial monolayer
conﬁguration was obtained by replicating a single DPPC molecule 64 times
as a monolayer in a box of size 6.4 3 6.4 3 30 nm. Then, ;6500 water
molecules were added below the headgroup region of the monolayer and
periodic boundary conditions were applied in all three directions. The large
distance between the lipid tails and the water molecules in the periodic image
in the z direction ensured that interactions among them were minimal. The
molecules in a water layer with a thickness of ;0.7 nm were position-
restrained to act as a wall. This barrier essentially disallows water in the bulk
to diffuse through and rejoin the lipid tail region. This monolayer leaﬂet was
equilibrated for 5 ns using conditions speciﬁed in Table 1. A cut-off was
used for van der Waals interactions and particle mesh Ewald summation
(PME) was used for electrostatic interactions (Essmann et al., 1995). The
temperature was maintained at 323 K by coupling the system to a Berendsen
thermostat (Berendsen et al., 1984). The pressure was controlled by
isotropically coupling to a Berendsen barostat at 1 atm pressure. Thus, the
volume of the system ﬂuctuated during this step. During the equilibration
run, we did not observe any water molecules diffuse either through the lipid
tails in the positive z direction or through the restrained water region in the
negative z direction. The ﬁnal conﬁguration from this equilibration
simulation was used as the starting condition for all the simulations.
Peptide insertion and equilibration
Peptides, listed in Table 2, were inserted into the equilibrated monolayer
obtained from step 1. The insertion into the monolayer was effected using
the ‘‘hole’’ protocol (Faraldo-Gomez et al., 2002). Brieﬂy, the molecular
surface of the peptide to be inserted was scanned using the program MSMS
(Sanner et al., 1996). Then, a molecular dynamics simulation was performed
on the monolayer with an additional hole-making force. This created a hole
corresponding to the molecular surface in the appropriate region of the lipid
monolayer. Then, the peptide was inserted into the hole and an energy
minimization step was performed with position restraints on the whole
peptide. Then, an appropriate number of counterions was added to ensure
electroneutrality of the system. After this step, the backbone atoms of the
peptide were position-restrained and an equilibration run of 1 ns was
performed in the NPzAT ensemble, allowing the lipids to equilibrate around
the peptide and the side chains to sample other conformations. The ﬁnal
conﬁguration from the equilibration run was the starting condition for the
production runs for all the simulations.
Production runs
All the peptides listed in Table 2 were inserted into the monolayer obtained
from step 1 using the protocol described in step 2. Then, a molecular dy-
namics simulation was performed on the whole system using conditions
speciﬁed in Table 1 in the NPzAT ensemble. The area of the system was
maintained at 62.5 A2/lipid. (This corresponds to the equilibrium area of the
simulation cell at the end of the equilibration run). In the z direction (axis
perpendicular to the water/lipid interface), a Berendsen barostat was applied
to maintain a pressure of 1 atm. The system was coupled to a Berendsen
temperature bath at 323 K. A cut-off was used for van der Waals interactions
and PME summation was used for calculation of the electrostatic in-
teractions. The bond lengths were constrained using the LINCS algorithm
(Hess et al., 1997). The simulations were 10 ns long with a time step of 2 fs.
The coordinates were saved every 500 steps (every ps) to give a trajectory
with 10,000 frames that was used for analysis.
RESULTS AND DISCUSSION
Simulations were carried out with the peptide initially
perpendicular to the interface (PER1, PER1, and PER3 in
Table 2) as well as initially parallel to the interface (PAR1,
PAR2, PAR3, PAR4, and PAR5). Since the exact position of
the peptide with respect to the interface is unknown
TABLE 1 Simulation parameters for the various stages
Lipid equilibration Peptide insertion Peptide-lipid equilibration Production run
Temperature (K) 323 323 323 323
Pressure (atm) 1 1 1 1
vdW cutoff (nm) 1.2 1.2 1.2 1.2
Electrostatics PME PME PME PME
Length of the run (ns) 5 0.05 1 10
Position restraints none Lipid phosphorus atoms* Peptide backbone none
Position restraint
force (kJ/mol/m2)
— 1000 1000 —
Hole making
force (kJ/mol/m2)
— 100 — —
vdW, van der Waals.
*During the peptide insertion stage, the lipid phosphorus atoms were position-restrained in the xy plane.
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experimentally (i.e., the depth of insertion), in most of the
simulations, we placed the peptide such that the Ca atom of
the W-9 residue was in the same z-position as the average
position of the lipid phosphorus atoms (PER1, PAR1–PAR3,
MUT1–MUT5). This is a reasonable starting condition since
the tryptophan residue is found to have a preferred interfacial
position in most membrane proteins. This also enables us to
compare our results with those of Kaznessis et al. (2002). We
also performed some simulations with subtly different initial
conditions (different depths of insertion) to study the effect
of initial condition on the ﬁnal conﬁguration of the peptide
(PER2, PER3, PAR4, and PAR5). Simulations were also
performed with mutated versions of the peptide (MUT1,
MUT2, MUT3, MUT4, and MUT5), where the speciﬁc
mutations are presented in Table 2. All the simulations were
performed for 10 ns each except for PER1, which was run for
20 ns. The results from PER1 will be discussed in detail, and
the results from the other simulations compared with these.
After a 1-ns equilibration run, during which the peptide
backbone was kept ﬁxed in position, a 20-ns production run
was performed. Snapshots from the beginning and the end of
the simulation are shown in Fig. 2. We can clearly see that
the peptide, which is initially in a vertical position, moves to
a ﬁnal conﬁguration with the major axis horizontal to the
interface. The angle formed by the helical portion of the
peptide with the membrane normal is shown in Fig. 3. This
angle is simply the angle between the z axis and the line
connecting the Ca atoms of residues W-9 and I-22. The
peptide is purported to be an a-helix between these residues
(although the secondary structure may change during the
duration of the simulation). This simple method of
calculation leads to fairly large ﬂuctuations in the tilt angle.
Moreover, this method does not take into account any major
secondary structure changes (such as kinks) in the in-
termediate residues. However, since the helix length is fairly
small, spanning ;15 residues, and we are just interested in
the overall orientation of the peptide, this method of
calculation is adequate for calculating the tilt angle. Using
this method, a 0 tilt angle (620) represents a vertical
orientation of the peptide and a 90 tilt angle (620)
represents a horizontal orientation of the peptide. Thus, Fig.
3 illustrates that the peptide changes over from an initial





Ca atom of peptide
in plane with average
position of lipid P8 atom
Total simulation
time (ns)
PER1 FPIPLPYCWLCRALIKRIQAMIPKG 90 W-9 20
PER2 FPIPLPYCWLCRALIKRIQAMIPKG 90 C-11 10
PER3 FPIPLPYCWLCRALIKRIQAMIPKG 90 A-13 10
PAR1 FPIPLPYCWLCRALIKRIQAMIPKG 0 W-9* 10
PAR2 FPIPLPYCWLCRALIKRIQAMIPKG 0 W-9* 10
PAR3 FPIPLPYCWLCRALIKRIQAMIPKG 0 W-9* 10
PAR4 FPIPLPYCWLCRALIKRIQAMIPKG 0 C-11 10
PAR5 FPIPLPYCWLCRALIKRIQAMIPKG 0 A-13 10
MUT1 WLCRALIKRIQAMIPKG 90 W-9 10
MUT2 FPIPLPYCWLCAALIAAIQAMIPAG 90 W-9 10
MUT3 WLCAALIAAIQAMIPAG 90 W-9 10
MUT4 FPIPLPYCWLCAALIKRIQAMIPAG 90 W-9 10
MUT5 LPYCWLCRALIKRIQAMIPKG 90 W-9 10
WAT FPIPLPYCWLCRALIKRIQAMPIKG — SP-B1–25 in water 20
All the PER simulations begin with the peptide perpendicular to the interface and the PAR simulations begin with the peptide parallel to the interface. MUT
simulations were performed on peptides that were mutated from the original sequence, and they begin with the peptide perpendicular to the interface.
PAR1, PAR2, and PAR3 differ in the orientation of the hydrophobic sequence (residues 1–8) with respect to the interface. In PAR1, the sequence is
embedded in the lipid tail region, in PAR2, the sequence is embedded in the water subphase, and in PAR3, the sequence is embedded in the interfacial region.
These orientations were achieved by rotating the peptide by 90 at a time about its principal helical axis. PER2 is inserted deeper into the lipid tail region than
is PER1, and PER3 is deeper than PER2.
FIGURE 2 Snapshots from the beginning
and end (20 ns) of simulation PER1. Initially,
the peptide is perpendicular to the water/lipid
interface. The ﬁnal conﬁguration is closer to
a parallel orientation. Note that the water
molecules have been omitted for the sake of
clarity.
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vertical position to a largely horizontal orientation at the end
of the simulation. This can be explained by the nature of the
interactions between the peptide and the lipid.
The lipid tail region, consisting of the acyl chains, is
highly hydrophobic and is devoid of any formal charges,
whereas the lipid headgroup region, consisting of the
phosphatidylcholine group, is a complex domain where
electrostatic interactions are likely to dominate. DPPC is
a zwitterionic lipid, i.e., it has no net charge, but it has a
charge distribution within the headgroup, which induces
a dipole moment. This enables the headgroups to form
hydrogen bonds with the peptides, especially with the
cationic amino acids. The headgroup of each DPPC
molecule has eight possible hydrogen-bond acceptors. The
peptide has a plethora of donor elements, some of them in the
peptide backbone and others in the polar side chains. These
hydrogen-bond interactions determine the ﬁnal conformation
of the peptide in the lipid environment. We show a schematic
representation of the lipid chain in Fig. 4. The hydrogen-
bond acceptor sites are present in the phosphate and glycerol
regions of the phospholipid. We have also labeled the
oxygens as O1–O4 in the phosphate region and O5–O8 in
the glycerol region. Due to the helical structure of the
peptide, the peptide backbone donors are not as easily
accessible to the lipid acceptors as are the peptide side
chains. Hence, we can expect side chain-lipid interactions to
be more prevalent and stronger than backbone-lipid
interactions. Analysis of the peptide sequence shows that
there are seven amino acids that are most likely to be
hydrogen-bond donors. They are tyrosine 7 (Y-7), trypto-
phan 9 (W-9), arginine 12 (R-12), lysine 16 (K-16), arginine
17 (R-17), glutamine 19 (Q-19), and lysine 24 (K-24).
Tyrosine and tryptophan have one hydrogen-bond donor
each, whereas the others have more donor sites: glutamine
has two donors, lysine has three, and arginine has ﬁve. These
donors can form hydrogen bonds with the acceptors of the
DPPC atoms to create a large hydrogen-bonded network,
which will play a crucial role in determining the conforma-
tion of the peptide in the lipid.
We analyzed the hydrogen-bonding characteristics of the
aforementioned amino acids during the course of the
simulation. Following a widely used criterion (Jeffrey and
Sanger, 1991), a hydrogen bond is said to exist if the donor-
acceptor distance is ,0.25 nm and the angle formed by the
donor-hydrogen-acceptor triplet is ,60. Analysis using
a stricter or looser criterion for bonding provided very
similar results qualitatively. For the sake of comparison we
have plotted, in Fig. 5, the number of hydrogen bonds
formed between the peptide and the lipids in simulation
PER1. We have used four different criteria for hydrogen
bonding. Along with the widely used 0.25-nm, 60 criterion,
we used a strict 0.25-nm, 30, an even stricter 0.2 nm, 30,
and an extremely liberal 0.25-nm, 180 criterion. We found
that, quantitatively, the different criteria produced different
results, as shown in Fig. 5, with a larger number of bonds
counted using the liberal criterion and fewer bonds counted
using the strictest criterion. However, qualitatively, the
curves show very similar trends. This is also observed from
hydrogen-bonding existence maps as will be discussed
shortly. Since a large amount of the discussion in this article
FIGURE 3 Angle formed by the helix with the membrane normal in
simulation PER1. With respect to the interface normal, 0 is perpendicular
and 90 is parallel. The helix tilt angle is calculated by measuring the angle
between the vertical z axis and the line formed by the Ca atoms of residues
C-8 and I-22. This shows that the peptide moves from an initial position that
is perpendicular to the lipid/water interface to a ﬁnal position that is mostly
parallel to the lipid/water interface.
FIGURE 4 A schematic representation of the lipid, showing the tail,
glycerol, phosphate, and choline regions. The oxygens in the phosphate and
glycerol region, which are the hydrogen-bond acceptor sites, are numbered,
and these indices are used in the discussion of hydrogen-bonding statistics.
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is based on the persistence of hydrogen bonds, it is important
to note that the results from the different criteria did not
affect the interpretation of the trends qualitatively. Hence,
the typical 0.25, 60 criterion was used for analysis of all the
trajectories. Note that according to the criterion we have used
a single donor could theoretically form more than one
hydrogen bond at any given time if there were a sufﬁcient
number of acceptor sites in the vicinity of the donor atom
that satisﬁed the hydrogen-bonding criterion. However, this
is highly unlikely due to geometric constraints.
At the beginning of the simulation, the W-9 residue and
the Y-7 residue are present in the interfacial region. R-12,
K-16, R-17, Q-19, and K-24 are in the water subphase.
Hence, the latter ﬁve residues do not have the ability to form
hydrogen bonds with the lipid at the beginning of the
simulation. However, these residues are free to form
hydrogen bonds with water, but these bonds are likely to
be short lived due to the high diffusivity of water. For these
reasons, the portion of the peptide in the water subphase is
likely to be very ﬂexible and sample more conﬁgurations
than the part of the peptide that is embedded in the lipid.
However, given enough time, the portion in the water
subphase will eventually be able to reconﬁgure to interact
with the lipid headgroups, and therefore be able to form
hydrogen bonds with the lipid. This phenomenon is shown in
Fig. 6 c, where the glutamine 19 residue forms its ﬁrst
hydrogen bond at ;10 ns and these bonds stay persistent
throughout the rest of the simulation.
Fig. 6 a shows the hydrogen-bond existence map for the
side chain of Y-7 and DPPC. Tyrosine has one donor atom
and each DPPC has eight possible acceptor atoms. Since
there are 64 DPPC lipids in the system, a total of 512 lipid
acceptors are present in the system. Hence, if the tyrosine
side chain is able to sample all of its possible conformational
space (i.e., given enough time), theoretically it could sample
512 unique hydrogen bonds. But due to the short timescale
of the simulation and the fact that the lipid diffusivity is
extremely low, the side chain can only sample a small
portion of its conformational space. So the tyrosine can form
hydrogen bonds only with the lipid acceptor atoms in its
immediate neighborhood. During the course of the 20-ns
simulation, it forms ﬁve unique hydrogen bonds. Analysis of
the bonding characteristics shows these bonds are formed
with just two of the neighboring DPPC molecules, one bond
with the ﬁrst DPPC molecule and four with the second. One
of those bonds (bond index number 2 in Fig. 6 a) is the most
persistent and is continuously present for long periods of
time. Note that in this ﬁgure, the indices are labeled from 0 to
4. Similar existence maps are shown for W-9 (12 unique
hydrogen bonds), R-12 (18 bonds), Q-19 (9 bonds), and
K-24 (30 unique bonds). K-16 and R-17 each formed just
one hydrogen bond, each lasting just a few picoseconds, and
hence those maps are not shown here. Note that K-16 and
R-17 form hydrogen bonds with water throughout the course
of the simulation. However, these hydrogen bonds are not
persistent due to the high diffusivity of water molecules.
At the beginning of the simulation, the Ca atom of theW-9
residue was placed at the interfacial region, in plane with
the average position of the phosphorus atom of the lipids.
This positioned the side chain of W-9 slightly above the
interfacial region, interacting with the acyl chains of the lipid
tail. Nevertheless, the side chain of this residue is close
enough to the acceptor groups that it is able to form hydrogen
bonds with the neighboring DPPC molecules. K-24 was
initially present deep in the water subphase, ;2 nm away
from the interface. However, after ;2 ns of simulation,
ﬂuctuations enabled it to move close enough to the interfacial
region to form hydrogen bonds with lipids. Once the residue
moved close enough to the lipid headgroups to interact, due
to the limited diffusivity of the lipid molecules in the
timescale of the simulation, the lysine residue stayed bound
to the lipid headgroup region. This is shown in Fig. 6 e. We
observe that although the lysine hydrogen bonds last
throughout the simulation, they are extremely intermittent,
frequently breaking and reforming. The lysine side chain can
form at least three unique hydrogen bonds at any given time
due to its three donor atoms, which compete for acceptors.
Because of ﬂuctuations and the abundance of acceptor sites,
all donors are electrostatically attracted to the different
acceptor sites simultaneously. This competition leads to
frequent bond formation and breaking and hence the
observed intermittency in the hydrogen-bonding character-
istics. Nevertheless, the donors still remain in the same
vicinity. In Fig. 6 e, although 30 unique hydrogen bonds are
observed, all these K-24 side-chain bonds are formed with
the acceptor sites of just three DPPC molecules during the
entire course of the simulation. This ‘‘pinning’’ of the K-24
and other amino acids by multiple hydrogen bonds is likely
to lead to a very low diffusivity of the peptide in the
monolayer, a diffusivity much too small to be measured in
a 20-ns simulation.
FIGURE 5 Number of hydrogen bonds between the peptide and lipid
using different geometric criteria for the deﬁnition of a hydrogen bond. The
geometric criterion uses a cut-off for the donor-acceptor distance and the
donor-hydrogen-acceptor angle. Although the different criteria predict
different numbers of hydrogen bonds, the qualitative trend is similar.
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Fig. 6 e shows the 30 unique hydrogen-bond indices as
a function of time. We can see three similar clusters of
hydrogen bonds, roughly grouped into indices 1–10, 11–20,
and 21–30. In Fig. 6 e, the ﬁrst 10 indices correspond to the
hydrogen bonds formed by the ﬁrst hydrogen of the lysine
side chain; the next 10 correspond to those formed by the
second hydrogen, and the last 10 correspond to those formed
by the third hydrogen. The interpretation of the hydrogen-
bond indices is facilitated by showing, on an expanded scale,
the ﬁrst 10 hydrogen bonds in Fig. 6 f. These 10 unique
hydrogen bonds are formed by different sets of nitrogen-
hydrogen-acceptor triplets, where the nitrogen and hydrogen
are the same in all 10 bonds, and the acceptors are 10 different
oxygens in the lipid headgroups. Analysis shows that a total of
three DPPC lipids form hydrogen bonds with this particular
lysine side chain, with the bulk of the bonding formed by
a single DPPC lipid. The speciﬁc acceptors corresponding to
each index in Fig. 6 e are tabulated in Table 3. Bond indices 1
and 10 are formed by lipids 1 and 3 (arbitrarily numbered),
whereas the other eight bonds are formed by the secondDPPC
molecule. The speciﬁc oxygens arementioned in the table and
they correspond to those labeled in Fig. 4. From Fig. 6 f, we
can see that bonds with indices 2 and 5 are the most persistent
in the simulation. These two oxygens correspond to the lipid
phosphate group (see Table 3). At ;12,000 ps, another
reasonably persistent hydrogen bond is formed, correspond-
ing toO5 of the lipid, which is present in the glycerol region. It
is interesting to note that in this particular case, the second
lipid uses all of its hydrogen-bond acceptor sites to interact
with the lysine side chain. Thus the interactions are highly
localized and this effectively restricts the mobility of the
peptide in the timescale of the simulations. Hydrogen-bond
existence maps using the stricter 0.20-nm, 30 criterion show
qualitatively identical behavior (data not shown).
Similar tendencies are observed in the case of Q-19 (Fig. 6
c), which ﬁrst encounters the interfacial region after ;10 ns
and then forms hydrogen bonds with the DPPC molecules.
However, in the case of R-12 (Fig. 6 d), the hydrogen
bonding with the DPPC interface is not so persistent despite
the fact that it is much closer to the interface at the beginning
of the simulation than is Q-19 or K-24. This is due to the fact
that the R-12 side chain is spatially constrained to remain in
the water subphase because of the sequence of earlier
hydrogen-bonding events, which anchor the peptide in
a position and orientation that makes R-12 unable to reach
the lipid interface. Thus, it forms a sparse number of hy-
drogen bonds compared to K-24, Y-7, W-9, or Q-19. Similar
spatial constraints disallow interactions of K-16 and R-17
with the DPPC headgroups.
From this simulation, a clearer picture of lipid-peptide
interactions emerges. Hydrogen bonding between the peptideFIGURE 6 Hydrogen-bond existence map for various amino acids
interacting with DPPC. Black implies the presence of a hydrogen bond
and white implies the absence of one. The y-coordinate shows the hydrogen-
bond index. Each index represents a unique donor-acceptor pair: (a) DPPC
and tyrosine-7; (b) DPPC and tryptophan-9; (c) DPPC and glutamine-19; (d)
DPPC and arginine-12; (e) DPPC and lysine-24; and (f) DPPC and lysine-
24-hydrogen 1 (Fig. 6 f is a subset of Fig. 6 e). A detailed explanation of the
individual bond indices corresponding to Fig. 6 f is shown in Table 3.
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and lipid headgroups is persistent and determines the
conformation of the peptide. The portion of the peptide in
the water subphase can sample a much larger conformational
space until it encounters the lipid interfacial region. Once the
amino acids that have hydrogen-bond donors get close
enough to the interface, they form hydrogen bonds with the
lipids, which pin the amino acid to the immediate vicinity of
the acceptor atoms. The hydrogen bonds thus greatly limit the
diffusivity of the peptide and the conformational space that
the peptide can sample, ultimately controlling the equilibrium
distribution of conﬁgurations of the peptide-lipid complex,
which is realized at simulation times too long to be achievable
by current computational methods. However, we can
conclude that the peptide prefers to reside in the interface
since this leads to the most favorable conﬁguration through
formation of hydrogen bonds. Although the discussion above
has been limited to the side chains, the peptide backbone also
forms hydrogen bonds with the DPPC acceptor headgroups.
However, these bonding events can be considered to be
byproducts of the side chain-lipid interactions, which largely
control the overall peptide-lipid interaction because of their
easier accessibility and hence higher probability of donor-
acceptor interaction.
Fig. 7 a shows the total number of hydrogen bonds
between the peptide and lipid over the course of the
simulation. The contributions from individual amino acids
are also shown. For the sake of clarity, a running average
over 20 ps has been plotted and thus the number of bonds can
be fractional and not necessarily an integer. In general, the
total number of hydrogen bonds between the peptide and the
lipids increases with time. Initially, when the peptide is
vertical with respect to the interface, very few amino acids
are in contact with the choline groups. As the simulation
progresses, more groups come into contact with the head-
groups, leading to more hydrogen bonds.
Table 4 provides some detailed hydrogen-bonding statis-
tics of PER1 and the other simulations. We show the total
number of hydrogen bonds between the following pairs at
early and late stages of the simulations: protein-lipid, protein-
water, lipid-water, and intramolecular protein hydrogen
bonds. The early stage is an average over the ﬁrst nanosecond
of the simulation, whereas the late stage corresponds to an
average over the last 10 ns for PER1 and the last 5 ns for all the













DPPC1, DPPC2, and DPPC3 refer to the three lipids that form hydrogen
bonds with the lysine in Fig. 6 f. O1–O8 refer to the eight different oxygens
(also see Fig. 4).
FIGURE 7 The number of hydrogen
bonds formed between DPPC and the
peptide SP-B1–25 and its component
amino acids in various simulations: (a)
PER1; (b) PER2; (c) PER3; and (d)
PAR3. To reduce the noise, a running
average over 20 ps is plotted here.
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other simulations. The standard deviations for all the values
provided in the table are small enough that statistically
meaningful trends from the early to late stages can be
elucidated. Fig. 7 a shows that the number of lipid-protein
interactions increases with time. Data from Table 4 also show
that the number of protein-water hydrogen bonds and lipid-
water hydrogen bonds decreases with time. This is to be
expected, since the peptide forms more hydrogen bonds with
the lipids as time increases. This effectively renders some of
the lipid (acceptor) sites and protein (donor and acceptor) sites
inaccessible to the water molecules. We also show the
intramolecular protein-protein hydrogen bonds in Table 4.
These hydrogenbonds aremostly just the 1–4hydrogenbonds
of the a-helical structure. We observe that for PER1, the
number of protein-protein hydrogen bonds decreases slightly
with time. This mostly has to do with subtle secondary-
structure rearrangements in the peptide.
Thus, PER1 shows that the peptide moves from an initially
vertical orientation to a mostly horizontal one, and in the
process, forms persistent hydrogen bonds with the lipid
headgroup regions. This also effectively reduces the number
of peptide-water and lipid-water hydrogen bonds.
Other simulations with an initially perpendicular
orientation of the peptide
To understand the effect of the initial position and orientation
of the peptide on its conformational evolution, we performed
many 10-ns simulations with different initial conditions than
those of PER1 (see Table 1). PER2 was simulated with the
peptide helix perpendicular to the interfacial plane (as in
PER1), but with the position of the Ca of the 11th residue
(a cysteine residue) at the same z-position as the average
phosphorus atom of the lipids. Since in PER1 the 9th residue
was placed at this position, in PER2 the peptide is inserted
more deeply into the lipid tail region than in PER1. This
positions Y-7 and W-9 farther away from the interface and
deeper into the lipid tail region, relative to PER1. This also
positions R-12 at the interface and places K-16, R-17, Q-19,
and K-24 closer to the interface than in PER1. With this
initial condition, the simulation was performed for 10 ns and
the number of hydrogen bonds formed is plotted in Fig. 7 b,
averaged over 20 ps. There are signiﬁcant differences in the
hydrogen-bonding characteristics between this run and
PER1. R-12 and K-16, which formed very few bonds in
PER1, form the most bonds in PER2. This is due to the fact
that R-12 is at the interface at the beginning of the simulation
and is able to form hydrogen bonds instantly. This can be
seen from Fig. 7 b, where R-12 forms ;5 bonds at the very
beginning of the simulation and continues to maintain ﬁve
bonds throughout the simulation. K-16, which is initially in
the water subphase, forms its ﬁrst hydrogen bond at ;1600
ns and continues to maintain that bond until the end of the
run at 10 ns. Interestingly, R-17 hardly forms any hydrogen
bonds. Again, this is a result of simple spatial constraints.
K-24 is also excluded from forming any hydrogen bonds
since it resides in the water subphase throughout the 10-ns
simulation. Another interesting observation is that W-9,
which is in the lipid tail region, hardly forms any hydrogen
bonds. Table 4 shows that PER2 also follows a similar trend
in the various hydrogen-bonding characteristics. We see an
increase in the number of protein-lipid hydrogen bonds as
the simulation progresses, and a decrease in the protein-
water and lipid-water hydrogen bonds.
Fig. 7 c shows the hydrogen-bonding characteristics of
simulation PER3, where the peptide was initially oriented
TABLE 4 Average number of hydrogen bonds formed at the early and late stages of the simulations for protein-lipid pairs,
protein-water pairs, lipid-water pairs, and intramolecular peptide hydrogen bonds
Run
Protein-lipid Protein-water Lipid-water Protein-protein
0–1 ns 5–10 ns 0–1 ns 5–10 ns 0–1 ns 5–10 ns 0–1 ns 5–10 ns
PER1 3.2 9.9 38.4 31.7 394 369 12 8.7
PER2 9.1 14.4 34.1 23.2 406 387 10.9 7.1
PER3 5.3 17.1 27.4 16.0 405 385 14.6 13.5
PAR1 14.8 19.4 19.9 11.8 400 388 11.8 11.9
PAR2 10.1 15.3 30.3 20.1 407 387 9.3 8.4
PAR3 16.2 28.1 27.8 15.5 397 368 6.0 5.8
PAR4 9.3 22.3 31.7 19.0 397 367 8.8 7.0
PAR5 14.5 17.8 12.7 11.1 388 372 13.8 13.1
MUT1 4.9 9.7 36.3 28.5 403 395 8.9 7.9
MUT2 1.6 5.4 26.3 21.5 400 378 13.3 8.0
MUT3 3.1 6.1 21.1 11.6 407 380 11.3 10.2
MUT4 3.6 11.8 31.3 23.6 403 382 12.3 7.9
MUT5 8.1 17.9 30.6 18.5 405 382 10.7 8.9
For the beginning of the simulations, the ﬁrst nanosecond is averaged and for the late stages of the simulation, the last 5 ns are averaged. For simulation
PER1, the last 10 ns are averaged for the late stages. The general trend is for the number of protein-lipid hydrogen bonds to increase with time, the protein-
water and lipid-water hydrogen bonds to decrease with time, and the intramolecular protein hydrogen bonds to stay constant or slightly decrease with time.
The standard deviations in all the values in this table are approximately of the magnitude 1. Hence, comparisons of early and late stages of a given simulation
are indeed statistically valid (except, in some cases, protein-protein interactions).
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vertically with the Ca atom of A-13 (alanine) positioned in
plane with the average lipid phosphorus atom. Thus, initially
R-12 is in the interfacial region, Y-7 and W-9 are in the lipid
tail region, and K-16, R-17, Q-19, and K-24 are all in the
water subphase. We observe no hydrogen bonding with Y-7,
since it is now deeper in the lipid tail region. W-9, which is
also in the lipid tail region (but closer to the interfacial region
than Y-7), shows sparse hydrogen bonding. R-12, K-16,
Q-19, and K-24 form persistent hydrogen bonds. The
interesting observation in this simulation is that although
R-17 is initially close to the headgroup region, over the
course of the simulation it only forms an average of two
hydrogen bonds (out of the possible ﬁve), and does so only
late in the simulation. Again, Table 4 shows similar trends
for this simulation as in PER1 and PER2.
Simulations with an initially parallel orientation
of the peptide
In both PER2 and PER3, the helix is initially vertical, and
adopts a ﬁnal orientation that is closer to horizontal (though
not fully horizontal) at the end of the 10-ns simulation, to
accommodate the side chain-lipid interactions. This suggests
that a horizontal orientation might be more favorable than
a vertical one. To test this idea, we performed ﬁve
independent simulations (PAR1, PAR2, PAR3, PAR4, and
PAR5), each 10 ns long, with different starting positions for
the peptide, but with the peptide helical axis parallel to the
interface. Results from one of these simulations (PAR3) is
shown in Fig. 7 d. The total number of hydrogen bonds
between the peptide and the lipid is higher in this simulation
than in PER1, PER2, or PER3 because all the side-chain
residues aremuch closer to the headgroups at the beginning of
the simulation than in the PER simulations. Y-7, R-12, K-16,
Q-19, andK-24 form persevering hydrogen bonds throughout
the course of the simulation. Even in this simulation, R-17 is
partially constrained and does not engage all of its donor
atoms in hydrogen bonding. W-9 again forms no hydrogen
bonds even though it resides very close to the interfacial
region. This behavior of W-9, both in this simulation and in
earlier PER simulations, can be explained by the bulkiness of
the tryptophan side chain and hence the ability to screen out
the donor nitrogen in most cases. Fig. 8 shows the total
number of hydrogen bonds between the peptide and lipids in
the six different simulations, three with initially vertical
peptides and three from initially horizontal peptides. As
a general trend, peptides with an initial horizontal orientation
form more hydrogen bonds with the lipid headgroups than
those that begin with a vertical orientation. This is to be
expected, since for horizontally oriented peptides the
hydrogen-bond donors are closer to the acceptor sites than
for vertically oriented peptides. In all the PER simulations, the
peptide helix orientation shifts from an initially vertical
orientation to an orientation that is tilted to varying degrees. In
all the PAR simulations, the ﬁnal peptide orientation
resembles the initial horizontal orientation. Fig. 9 shows the
helix tilt angles of all these simulations. Thus, in the timescale
of these simulations, it is clear that almost all the initial
conﬁgurations favor a ﬁnal conﬁguration in which the peptide
helix lies parallel to the interface and this phenomenon can be
explained purely in terms of maximization of hydrogen
bonding between the peptide and the lipid. The analysis of the
peptide-water and lipid-water hydrogen bonds for the PAR
simulations show trends similar (Table 4) to the PER
simulations. Although the absolute magnitudes differ, the
number of lipid-peptide hydrogen bonds increases, and the
number of lipid-water and water-peptide hydrogen bonds
decreases with time. This correlates well with the tendency to
orient to a more parallel orientation, thus reducing the ac-
cessibility of the water molecules to some of the protein and
lipid surface area.
FIGURE 8 The total number of hydrogen bonds formed between DPPC
and the peptide SP-B1–25 in six different simulations. PER1, PER2, and
PER3 have an initial perpendicular orientation for the peptide with different
depths of insertion (PER3 inserted deepest and PER1 shallowest), whereas
PAR1, PAR2, and PAR3 have initial parallel orientations. For the sake of
clarity, a running average over 20 ps is plotted here. As a general trend,
peptides with an initial horizontal orientation form more hydrogen bonds.
FIGURE 9 Tilt angle of the a-helix with respect to the z axis. With respect
to the interface, 0 represents a vertical orientation, whereas 90 represents
a horizontal orientation. Peptides that start from a horizontal conﬁguration
tend to stay horizontal whereas peptides with an initially vertical orientation
tilt toward a more horizontal orientation.
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We observed that all peptides bob, twist, and tilt to
accommodate the tendency of the side-chain donors to form
hydrogen bonds with the lipid headgroups. This causes the
secondary structure of the peptide backbone to change with
time. As mentioned earlier, the ﬁrst eight amino acids of the
peptide form a coil motif, residues 9–22 form an a-helix, and
the last few residues form a coil. This is themeasured structure
of SP-B1–25 in POPG lipids (Gordon et al., 2000). During the
course of the simulation, this secondary structure of the
peptide changes. We broadly capture that effect in Table 4 by
observing the intramolecular hydrogen bonds of the peptide.
At early stages, the peptide is close to the initial structure.
However, as time progresses, the peptide secondary structure
changes, due to interactions with water and the lipid. In
general, the ends of the peptide fray due to interactions with
water and slight unraveling of the peptide. This leads to
a reduction in the number of peptide-peptide hydrogen bonds.
The secondary structure change is fairly subtle in most of the
simulations performed in this work. However, some of the
simulations do show drastic changes in the secondary
structure of the peptide. Fig. 10 shows the secondary-structure
proﬁle from different simulations. PER2 shows a drastic
change in secondary structure between ;2 and 8 ns of the
simulation, especially in residues 9–22, which is the a-helical
region. This represents the period of time during which the
cationic side chains are forming hydrogen bonds. The peptide
backbone accommodates this by breaking some of the
intramolecular hydrogen bonds. This leads to unraveling of
the a-helix and formation of a p-helix structure, which is
amore looselywound secondary structure than the originala-
helix. This enables the side chains to sample a larger
conformational space and form hydrogen bonds. During the
last 2 ns of the simulation, we observe some parts of the
p-helix fold back to an a-helix motif.
In simulation PAR3 in Fig. 10, the peptide is initially in
the interfacial region. Thus, most of the side-chain donors are
accessible for hydrogen bond formation from the start of the
simulation and therefore not much conformational rearrange-
ment of the backbone is necessary to achieve the favorable
hydrogen bonding. Hence, the peptide backbone remains
fairly stable throughout the simulation. Note that although
residues 9–22 of the peptide are a-helical during the initial
simulation set up process, some of the helicity is lost during
the equilibration stage, especially in residues 9–12 and 19–
22. Nonetheless, the secondary structure is fairly stable
(although it is not uniformly the expected a-helical structure)
throughout the PAR simulations, whereas drastic rearrange-
ments occur in PER simulations. This phenomenon is also
generally observed in the other PAR and PER simulations
(data not shown). For the sake of comparison, the secondary
structure of the peptide simulated in a bath of water is also
shown. We observe that loss of secondary structure is fairly
severe in this simulation. Thus, we can see that the peptide
tends to fray along the terminus when in contact with water.
This could explain some of the loss in secondary structure of
the peptide in all the simulations with the lipids and water,
since the peptides in those simulations are always sur-
rounded by a large number of water molecules, depending on
the initial conditions.
Thus, from the series of PAR and PER simulations, some
general conclusions can be drawn. The peptides seem to
prefer a horizontal orientation to maximize the contact
between the donor side chains and the lipid headgroups. The
secondary structure of the peptide is also modiﬁed to enable
this. The interactions between the cationic amino acids and
the headgroup seem to be fairly important. It is commonly
believed that the ﬁrst eight amino acids of the peptide form
an insertion sequence and it is extremely important in an-
choring the peptide to the interface. To further study the
importance of the charged amino acids and the insertion
sequence, we performed a few more simulations where the
peptide was mutated at select amino acids.
Mutated peptides
We performed ﬁve simulations (MUT1–MUT5) of mutated
peptides in DPPC monolayers. Details of the amino acid se-
quences of the peptides are provided in Table 2. The initial
FIGURE 10 Secondary-structure proﬁle of peptides in (a) simulation
PER2, where the peptide is initially perpendicular to the interface; (b)
simulation PAR3, where the peptide is initially parallel to the interface; and
(c) a simulation of SP-B1–25 in water to show the destabilizing effect of water
on the secondary structure.
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peptide orientation in all these simulations is vertical, similar
to PER1, with the Ca atom of the W-9 residue in plane with
the average position of the phosphorus atoms. In MUT1, the
entire insertion sequence is removed to give a shorter version
of the peptide. In MUT2, all the lysines and arginines are
replaced by alanines to give a neutral peptide. MUT3 is
a combination of MUT1 and MUT2 in that the insertion
sequence is removed and the charged amino acids are
mutated to alanines. In MUT4, only two of the charges are
removed (R-12 and K-24) and replaced by alanines; and in
MUT5, only the ﬁrst four residues of the insertion sequence
are removed to give a 21-amino acid-long peptide. These
mutations give us a broad enough spectrum of changes to
decipher the importance of the insertion sequence and the
cationic amino acids.
From Table 4, we can observe that, as expected, MUT2
and MUT3 (which have no charged residues) form the
fewest hydrogen bonds and MUT5 forms the most hydrogen
bonds, with MUT1 and MUT4 in between. Because of the
lack of charges on the side chains, all the hydrogen bonding
in MUT2 and MUT3 mutants occurs through donors on the
peptide backbone and polar side chains. MUT4 has two of
the charged groups still remaining and hence it interacts
more strongly with the DPPC than either MUT2 or MUT3.
MUT1 and MUT5 have all the cationic residues intact. Thus,
they should have stronger interactions with the lipid
headgroup when compared to the other three mutants. The
insertion sequence is believed to anchor the peptide in
the interfacial region and determine the orientation of the
peptide. Fig. 11 depicts the helical tilt angle of all the MUT
simulations. Unlike the PER and PAR simulations, in these
simulations with mutated peptides, we observe widely
varying behavior. MUT1, which has no insertion sequence,
shows wild ﬂuctuations about an average tilt angle of 20
with the z axis, which is a nearly perpendicular orientation.
This lends credence to the hypothesis that the insertion
sequence is necessary to stably anchor the peptide at the
interface. MUT2, which has the insertion sequence but no
charged residues, also shows ﬂuctuations similar to MUT1,
indicating that lack of hydrogen bonding also leads to
ﬂuctuating orientations. These two simulations behave as
expected from the earlier analyses. However, unexpectedly,
MUT3, which is both truncated and uncharged, seems to
show a steady trend toward a more tilted orientation from the
initial vertical position. This can perhaps be explained by the
fact that due to the lack of both an insertion sequence and
charges, the peptide resides mostly in the water subphase and
has a greater conformational freedom than the peptides in the
other simulations. Also, due to the truncations, the ﬁrst
residue in this mutant happens to be W-9, which is assumed
to be one of the ends of the helix for the tilt angle calcu-
lations. Because this W-9 is a terminal residue, it tends to be
more frayed than a W-9 residue in the middle of a sequence.
MUT4, which lacks two of the ﬁve charged amino acids,
shows a similar trend, tending toward a more horizontal
orientation. Toward the end of the simulation, the trend is
slightly reversed, but nevertheless the overall orientation tilts
away from the vertical position.
Table 4 shows that of all the mutated peptides, MUT5
forms the most hydrogen bonds with DPPC. This is to be
expected since it has all the charged residues and the
insertion sequence is partially present. Thus, of all the
mutated peptides, we should expect MUT5 to behave most
similarly to the unmutated peptide. This is apparent in the
hydrogen-bonding characteristics. However, the peptide
does not rotate toward a parallel orientation as occurs in
simulations PER1, PER2, and PER3. This can be explained
by analyzing the peptides’ conformations and proximity to
lipid donors. As observed in almost all the PER simulations,
some of the cationic residues do not hydrogen-bond with the
lipids or do so sparingly. This is because they are either in the
water subphase away from the interface or are conforma-
tionally disallowed to form bonds. We observed this
especially in adjacent residues K-16 and R-17. Both these
residues have long side chains that can ‘‘snorkel’’ through
the water to ﬁnd favorable interactions with the lipid. How-
ever, as a peptide tilts itself toward the lipid headgroup
region, if both the residues happen to be on the side of the
helix that is away from the interface, then in the simulation
time available, not all of the seven donor side chains will be
able to ﬁnd suitable acceptors. Longer times will eventually
permit all the donor atoms to ﬁnd acceptor atoms to form
persistent hydrogen bonds, through changes in the secondary
structure of the peptide. MUT5 represents a case where all
the donor amino acids ﬁnd suitable acceptor sites within the
timescale of the simulation (although such a trajectory or
sequence of events is a low-probability-event). Thus, the
peptide does not need to alter its secondary structure to
enable these favorable events. This can also be clearly seen
in Fig. 12, which shows that the secondary structure of the
peptide remains fairly constant with time, with a well-
preserved a-helical content. A snapshot from the ﬁnal stages
FIGURE 11 Tilt angle with respect to the z axis of the a-helix of mutated
peptides (simulations MUT1–MUT5). With respect to the interface, 0
represents a vertical orientation whereas 90 represents a horizontal
orientation.
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of the simulation is shown in Fig. 13. The four charged
residues—R-12, K-16, R-17, and K-24—are shown as blue
bonds. The phosphorus atoms are drawn as van der Waals
spheres for reference. We can see that all four residues
manage to interact with the lipid interface region in this
snapshot. This is the reason for the large number of hydrogen
bonds and relative stability of the peptide. Water has not
been shown for the sake of clarity.
Thus, the results from the study ofmutated peptides suggest
that the insertion sequence is probably necessary to anchor the
peptide at the interface. They also suggest that the charged
amino acids are essential for binding the peptide to the
interface. Some inconsistencies in the orientation of the
peptide are observed in some of the MUT simulations. A
strongly bonded peptide in MUT5, coupled with ﬂuctuating
tilt angles and a highly preserved secondary structure, seems
to suggest that a parallel orientation of the peptide is not
a necessary condition for strong binding. However, when the
results of all the simulations are put into perspective, it is clear
that ahorizontal orientation is themost likely andenergetically
favorable position since itmaximizes the interactions between
the cationic side chains and the zwitterionic headgroups.
Having discussed in detail the peptide orientation, we
discuss the relative positions of the peptide with respect to
the interface. In most of the simulations, the initial position
of the peptide was such that the backbone carbon atom of the
tryptophan residue was in plane (same z-coordinate) with the
average lipid phosphorus atom. This was an arbitrary, but
reasonable, choice. Some of the simulations had slightly
different insertion depths (see Table 2), but in no case
differing by .0.5 nm from the standard case (Ca of the W
residue in plane with phosphorus). The lipid/water interfacial
region is fairly wide and we are interested in observing the
position of the peptide, speciﬁcally the tryptophan residue, as
the simulation progresses. The position of the backbone
carbon atom of the tryptophan residue as a function of
simulation time is plotted for some of the simulations in
Fig. 14. We have only shown six simulations for the sake of
clarity. In this ﬁgure, the zero position corresponds to the
average position of the phosphorus atoms in the DPPC
bilayer. Positive values correspond to positions above the
phosphorus plane (i.e., deeper into the lipid tail region), and
negative values correspond to positions below the phospho-
rus plane (i.e., closer to the water subphase). See Fig. 1 for
reference. We can see that, after 10-ns runs, the general trend
is for the Ca atom of the tryptophan residue to reside ;0.5
nm above the average phosphorus atom. Similar trends were
observed for a few of the other simulations not shown in this
ﬁgure. However, it must be mentioned that in two of the
simulations not shown here, the average position of the
tryptophan residue was below the average phosphorus plane.
Nevertheless, our simulations show that the overall trend was
for the Ca atom of the tryptophan residue to reside a few
Angstroms above the plane formed by the phosphorus atoms
of the lipid. The inset in Fig. 14 shows the position of the
tryptophan residue in simulation PER1. Although at early
stages, the peptide has a shallow proﬁle, after 15 ns, the
peptide inserts itself deeper into the lipid bilayer. Thus,
typically the peptide’s position at the end of the simulation is
FIGURE 13 Snapshot of the simulation MUT5 at 10 ns. The peptide is
shown as ribbons. TheDPPC lipid is drawn as lines. The charged amino acids
are depicted as blue bonds. The phosphorus atoms of the lipid molecules are
drawn as spheres to clarify the approximate position of the interface. Water
molecules are not shown. Observe that all the charged amino acids are in the
lipid/water interface region, leading to a large number of hydrogen bonds and
a stable peptide secondary structure and relative orientation.
FIGURE 14 The average position of the backbone carbon of the
tryptophan residue in some of the simulations. Zero on the y axis represents
the average position of the lipid phosphorus atoms. A positive value
corresponds to a deeply inserted position (closer to the lipid tails) and
a negative value corresponds to a shallower position (closer to the water
subphase). The general trend is for the tryptophan residue to reside ;5 A˚
above the phosphorus plane. The inset shows the longer PER1 simulation.
FIGURE 12 Secondary structure of the peptide in simulation MUT5.
Note that the secondary structure is highly conserved throughout the
simulation.
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such that the tryptophan residue is anchored in the interfacial
region at a tilted orientation. An earlier, much shorter
simulation by Kaznessis et al. (2002) showed that the peptide
was expelled into the water subphase in DPPC monolayers.
We do not observe that phenomenon in our simulations.
Recent experimental results using ﬂuorescence quenching
(Wang et al., 2003) predicted the location and depth of each
residue of the SP-B1–25 peptide in a model phospholipid
bilayer. This bilayer was a mixture of DPPC, cholesterol, and
anionic PG. However, since DPPC was the major compo-
nent, we presume that their results can be compared with
ours, at least as a ﬁrst approximation. Their results showed
that residues F-1 through P-6 are present at the interface,
residues Y-7, C-8, and W-9 are present in the lipid tail
region, residues L-10 through I-22 form an a-helix which
has its axis parallel to the interface, and residues P-23, K-24,
and G-25 lie at the interface. Our 10- to 20-ns-long
simulations agree well with these results. The simulation
that most resembles the conformation from this experiment is
PAR3, where the peptide was initially placed parallel to the
interface. Interestingly, this simulation forms the most
hydrogen bonds, suggesting the most favorable position.
Their results also show that this position and orientation is
consistent with that of the SP-B1–25 domain in the naturally
occurring full-length protein SP-B1–78. This also supports
earlier reports suggesting a shallow proﬁle for the peptide
rather than a vertical or an inserted proﬁle.
The supposed function of SP-B1–78 (and, presumably of
SP-B1–25) is to interact with both DPPC and the anionic lipids
to maintain the ‘‘squeezed out’’ lipids directly under the
monolayer so that they can respread during the expansion
cycle of the lung. In this study, we focused on the interactions
between SP-B1–25 and DPPC. The other important interaction
that needs to be studied is the one between SP-B1–25 and the
anionic lipids DPPG and POPG. Note that these interactions
are likely to be different from the DPPC-peptide interactions.
From the perspective of hydrogen bonding, DPPC lipids
possess only acceptor sites. However, DPPG and POPG,
which have a glycerol headgroup, have both donor and
acceptor sites. This will probably drastically change the
electrostatic interactions between the peptide and lipid.
Understanding this difference in interactions between the
peptide and the lipid at a molecular level could be a very
important step to understanding squeeze-out. Simulations of
DPPG lipids and SP-B1–25 peptide are currently under way.
We have also performed some simulations of SP-B1–25
peptide in palmitic monolayers.
We simulated in the NPzAT ensemble, where the lateral
area was ﬁxed and the pressure was allowed to ﬂuctuate in the
z direction. However, in vivo, the LS monolayer constantly
undergoes changes in surface area. Obviously this slow
(milliseconds to seconds) process cannot be simulated by
molecular dynamics. However, it is probably a wise idea to
simulate the same system at different surface areas and using
different ensembles. Hydrogen bonding by the peptide is
highly dependent on the distribution of acceptor and donor
sites around the peptide. A different surface area could change
the charge distribution, which in turn can change the
hydrogen-bonding characteristics.
Earlier experimental results by Lee et al. (2001) on palmitic
acid (PA) monolayers suggested a tilted orientation for the
peptide. Palmitic acid is a minor component of LS. However,
it is easier to characterize experimentally than lipids with
bulky headgroups. Palmitic acid has a very small headgroup
and does not possess as many bonding sites as a choline
headgroup. Hence, we speculate that the peptide can sample
more conformations in a PA monolayer than in a DPPC
monolayer and can diffuse around more freely. Thus, a tilted,
rather than horizontal, orientation is not unlikely in PA
monolayers. Synthetic peptides with amphipathic properties,
such as KL4 (sequence: K(L4K)3L4K) and RL4, have been
partially successful in restoring proper respiratory function.
Studies of these simpler peptides could also yield a better
understanding of lipid-peptide interactions at a molecular
scale.
SUMMARY AND CONCLUSIONS
Simulations of DPPC monolayers with SP-B1–25 peptide and
its mutants have provided many insights into the nature of
the interactions between the peptides and the lipids.
Zwitterionic DPPC has a tendency to form hydrogen bonds
with the polar and cationic amino acids of the peptide. These
bonding interactions dictate the structure, orientation, and
positioning of the peptide in the lipid/water interface.
Simulations with different starting conditions suggest that
the most favorable position for the peptide is with its helical
axis parallel to the interface. This position optimizes the
hydrogen-bonding probability of the peptide by exposing its
side chains to a maximum number of external donor and
acceptor sites. Although peptides in some of the simulations
did not reach a near-horizontal orientation on the timescale
of the simulation due to locally trapped minima, longer
simulations will probably produce nearly horizontal orienta-
tions. The peptide backbone secondary structure ﬂuctuates
through breakage of intramolecular hydrogen bonds, which
enables the formation of intermolecular hydrogen bonds by
the side-chain groups. All the simulations showed a similar
trend of increasing peptide-lipid hydrogen bonds, along with
decreasing peptide-water and lipid-water interactions. Using
different criteria for hydrogen bonding showed slightly
different quantitative behavior but nearly identical qualita-
tive behavior. We also observe that the depth of insertion is
fairly conserved, with the tryptophan residues lingering a few
Angstroms above the average phosphorus position of the
lipid, in the interfacial region. We do not observe drastic
extremes in positions, like insertion into the lipid tail region
or expulsion from the bilayer in the timescale of the
simulations. Our simulation results match reasonably well
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with existing experiments that also show a horizontal
equilibrium orientation of the peptide.
The most immediate issues that need to be addressed
include the nature of interactions of these peptides with
anionic lipids with charged headgroups, such as POPG, and
fatty acids with small headgroups, such as palmitic acid.
Longer simulations might clarify a few of the conﬂicting
trends observed in the simulations with DPPC presented
here. Another important goal will be to study the interactions
of simpler model peptides such as KL4 and RL4. These
simulations could yield insights into the rational design of
synthetic lung surfactants and, more importantly, a better
fundamental understanding of the molecular interactions be-
tween lipids and peptides, one of the most common, yet least
understood, aspects of molecular biology.
REFERENCES
Berendsen, H. J. C., J. P. M. Postma, W. F. van Gunsteren, A. Dinola, and
J. R. Haak. 1984. Molecular dynamics with coupling to an external bath.
J. Chem. Phys. 81:3684–3690.
Berendsen, H. J. C., D. van der Spoel, and R. van Drunen. 1995.
GROMACS: A message-passing parallel molecular dynamics imple-
mentation. Comput. Phys. Commun. 91:43–56.
Bruni, R., J. M. Hernandez-Juviel, R. Tanoviceanu, and F. J. Walther.
1998. Synthetic mimics of surfactant proteins B and C: In vitro surface
activity and effects on lung compliance in two animal models of
surfactant deﬁciency. Mol. Genet. Metab. 63:116–125.
Chu, J., J. A. Clements, E. K. Cotton, M. H. Klaus, A. Y. Sweet, and W. H.
Tooley. 1967. Neonatal pulmonary ischemia. I. Clinical and physiolog-
ical studies. Pediatrics. 40:709–782.
Clark, J. C., S. E. Wert, C. J. Bachurski, M. T. Stahlman, B. R. Stripp, T. E.
Weaver, and J. A. Whitsett. 1995. Targeted disruption of the surfactant
protein B gene disrupts surfactant homeostasis, causing respiratory
failure in newborn mice. Proc. Natl. Acad. Sci. USA. 92:7794–7798.
Creuwels, L. A. J. M., L. M. G. van Golde, and H. P. Haagsman. 1996.
Surfactant protein B: effects on lipid domain formation and intermem-
brane lipid ﬂow. Biochim. Biophys. Acta. 1285:1–8.
Cruz, A., C. Casals, I. Plasencia, D. Marsh, and J. Perez-Gil. 1998. Depth
proﬁles of pulmonary surfactant protein B in phosphatidylcholine
bilayers, studied by ﬂuorescence and electron spin resonance spectros-
copy. Biochemistry. 37:9488–9496.
Dieudonne, D., R. Mendelsohn, R. S. Farid, and C. R. Flach. 2001.
Secondary structure in lung surfactant SP-B peptides: IR and CD studies
of bulk and monolayer phases. Biochim. Biophys. Acta. 1511:99–112.
Essmann, U., L. Perera, M. L. Berkowitz, T. Darden, H. Lee, and L. G.
Pedersen. 1995. A smooth particle mesh Ewald method. J. Chem. Phys.
103:8577–8593.
Faraldo-Gomez, J. D., G. R. Smith, and M. S. P. Sansom. 2002. Setting up
and optimization of membrane protein simulations. Eur. Biophys. J.
31:217–227.
Gordon, L. M., S. Horvath, M. L. Longo, J. A. Zasadzinski, H. W. Taeusch,
K. Faull, C. Leung, and A. J. Waring. 1996. Conformation and molecular
topography of the N-terminal segment of surfactant protein B in
structure-promoting environments. Protein Sci. 5:1662–1675.
Gordon, L. M., K. Y. C. Lee, M. M. Lipp, J. A. Zasadzinski, F. J. Walther,
M. A. Sherman, and A. J. Waring. 2000. Conformational mapping of the
N-terminal segment of surfactant protein B in lipid using C-13-enhanced
Fourier transform infrared spectroscopy. J. Pept. Res. 55:330–347.
Hall, S. B., A. R. Venkitaraman, J. A. Whitsett, B. A. Holm, and R. H.
Notter. 1992. Importance of hydrophobic apoproteins as constituents of
clinical exogenous surfactants. Am. Rev. Respir. Dis. 145:24–30.
Hess, B., H. Bekker, H. J. C. Berendsen, and J. G. E. M. Fraaije. 1997.
LINCS: A linear constraint solver for molecular simulations. J. Comput.
Chem. 18:1463–1472.
Humphrey, W., A. Dalke, and K. Schulten. 1996. VMD: visual molecular
dynamics. J. Mol. Graph. 14:33–38.
Jeffrey, G. A., and W. Sanger. editors.1991. Hydrogen Bonding in
Biological Structures. Springer Verlag, Berlin.
Kaznessis, Y. N., S. Kim, and R. G. Larson. 2002. Speciﬁc mode of
interaction between components of model pulmonary surfactants using
computer simulations. J. Mol. Biol. 322:569–582.
Kruger, P., M. Schalke, Z. D. Wang, R. H. Notter, R. A. Dluhy, and M.
Losche. 1999. Effect of hydrophobic surfactant peptides SP-B and SP-C
on binary phospholipid monolayers. I. Fluorescence and dark-ﬁeld
microscopy. Biophys. J. 77:903–914.
Lee, K. Y. C., J. Majewski, T. L. Kuhl, P. B. Howes, K. Kjaer, M. M. Lipp,
A. J. Waring, J. A. Zasadzinski, and G. S. Smith. 2000. The
incorporation of lung surfactant speciﬁc protein SP-B into lipid
monolayers at the air-ﬂuid interface. Proc. Materials Research Society
Symposium on Applications of Synchrotron Radiation Techniques to
Material Science. 590:177–182.
Lee, K. Y. C., J. Majewski, T. L. Kuhl, P. B. Howes, K. Kjaer, M. M. Lipp,
A. J. Waring, J. A. Zasadzinski, and G. S. Smith. 2001. Synchrotron
x-ray study of Lung surfactant-speciﬁc protein SP-B in lipid mono-
layers. Biophys. J. 81:572–585.
Lindahl, E., B. Hess, and D. van der Spoel. 2001. GROMACS 3.0: A
package for molecular simulation and trajectory analysis. J. Mol. Model.
7:306–317.
Nag, K., J. G. Munro, K. Inchley, S. Schurch, N. O. Petersen, and F.
Possmayer. 1999. SP-B reﬁning of pulmonary surfactant phospholipid
ﬁlms. Am. J. Physiol. 277:L1179–L1189.
Nogee, L. M., D. E. DeMello, L. P. Dehner, and H. R. Colten. 1993. Brief
report: deﬁciency of pulmonary surfactant protein B in congenital
alveolar proteinosis. N. Engl. J. Med. 328:406–410.
Oosterlaken-Dijksterhuis, M. A., H. P. Haagsman, L. M. G. van Golde, and
R. A. Demel. 1991. Characterization of lipid insertion into mono-
molecular layers mediated by lung surfactant proteins SP-B and SP-C.
Biochemistry. 30:10965–10971.
Pastrana-Rios, B., C. R. Flach, J. W. Brauner, A. J. Mautone, and R.
Mendelsohn. 1994. A direct test of the squeeze-out hypothesis of the
lung surfactant function: external reﬂection FTIR at the air-water
interface. Biochemistry. 33:5121–5127.
Piknova, B., V. Schram, and S. B. Hall. 2002. Pulmonary surfactant: phase
behavior and function. Curr. Opin. Struct. Biol. 12:487–494.
Pryhuber, G. S. 1998. Regulation and function of pulmonary surfactant
protein B. Mol. Genet. Metab. 64:217–228.
Revak, S. D., T. A. Merritt, C. G. Cochrane, G. P. Heldt, M. S. Alberts,
D. W. Anderson, and A. Kheiter. 1996. Efﬁcacy of synthetic peptide-
containing surfactant in the treatment of respiratory distress syndrome in
preterm infant rhesus monkeys. Pediatr. Res. 39:715–724.
Revak, S. D., T. A. Merritt, M. Hallman, G. Heldt, R. J. La Polla, K. Hoey,
R. A. Houghten, and C. G. Cochrane. 1991. The use of synthetic peptides
in the formation of biophysically and biologically active pulmonary
surfactants. Pediatr. Res. 29:460–465.
Sanner, M. F., A. J. Olson, and J. C. Spehner. 1996. Reduced surface: an
efﬁcient way to compute molecular surfaces. Biopolymers. 38:305–320.
Schurch, S., F. H. Y. Green, and H. Bachofen. 1998. Formation and structure
of surface-ﬁlms: captive bubble surfactometry. Biochim. Biophys. Acta.
1408:180–202.
Schurch, S., R. Qanbar, H. Bachofen, and F. Possmayer. 1995. The surface-
associated surfactant reservoir in the alveolar lining. Biol. Neonate.
67:61–76.
Simon, A. S., and T. J. McIntosh. 2002. Peptide-Lipid Interactions.
Academic Press, London.
MD Simulations of Lung Surfactant 1591
Biophysical Journal 88(3) 1577–1592
Taneva, S., and K. M. W. Keough. 1994a. Pulmonary surfactant proteins
SP-B and SP-C in spread monolayers at the air-water interface. I. Mono-
layers of pulmonary surfactant protein SP-B and phospholipids. Biophys.
J. 66:1137–1148.
Taneva, S., and K. M. W. Keough. 1994b. Pulmonary surfactant proteins
SP-B and SP-C in spread monolayers at the air-water interface. II.
Monolayers of pulmonary surfactant protein SP-C and phospholipids.
Biophys. J. 66:1149–1157.
Wang, Y. D., K. M. K. Rao, and E. Demchuk. 2003. Topographical
organization of the N-terminal segment of lung pulmonary surfactant
protein B (SP-B1–25) in phospholipid bilayers. Biochemistry. 42:4015–
4027.
Yu, S. H., and F. Possmayer. 1990. Role of bovine pulmonary surfactant-
associated proteins in the surface-active property of phospholipid mix-
tures. Biochim. Biophys. Acta. 1046:233–241.
Yu, S. H., and F. Possmayer. 1992. Effect of pulmonary surfactant
protein B (SP-B) and calcium on phospholipid adsorption and
squeeze-out of phosphatidylglucerol from binary phospholipid
membranes contatining; dipalmitoylphosphatidylcholine. Biochim.
Biophys. Acta. 1126:26–34.
1592 Kandasamy and Larson
Biophysical Journal 88(3) 1577–1592
